337 related articles for article (PubMed ID: 24613671)
1. Altered lipid composition in cortical lipid rafts occurs at early stages of sporadic Alzheimer's disease and facilitates APP/BACE1 interactions.
Fabelo N; Martín V; Marín R; Moreno D; Ferrer I; Díaz M
Neurobiol Aging; 2014 Aug; 35(8):1801-12. PubMed ID: 24613671
[TBL] [Abstract][Full Text] [Related]
2. Biophysical alterations in lipid rafts from human cerebral cortex associate with increased BACE1/AβPP interaction in early stages of Alzheimer's disease.
Díaz M; Fabelo N; Martín V; Ferrer I; Gómez T; Marín R
J Alzheimers Dis; 2015; 43(4):1185-98. PubMed ID: 25147112
[TBL] [Abstract][Full Text] [Related]
3. Anomalies occurring in lipid profiles and protein distribution in frontal cortex lipid rafts in dementia with Lewy bodies disclose neurochemical traits partially shared by Alzheimer's and Parkinson's diseases.
Marin R; Fabelo N; Martín V; Garcia-Esparcia P; Ferrer I; Quinto-Alemany D; Díaz M
Neurobiol Aging; 2017 Jan; 49():52-59. PubMed ID: 27768960
[TBL] [Abstract][Full Text] [Related]
4. Targeting ADAM10 to lipid rafts in neuroblastoma SH-SY5Y cells impairs amyloidogenic processing of the amyloid precursor protein.
Harris B; Pereira I; Parkin E
Brain Res; 2009 Nov; 1296():203-15. PubMed ID: 19679113
[TBL] [Abstract][Full Text] [Related]
5. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
6. Decrease in brain soluble amyloid precursor protein β (sAPPβ) in Alzheimer's disease cortex.
Wu G; Sankaranarayanan S; Hsieh SH; Simon AJ; Savage MJ
J Neurosci Res; 2011 Jun; 89(6):822-32. PubMed ID: 21433051
[TBL] [Abstract][Full Text] [Related]
7. Decreased expression of GGA3 protein in Alzheimer's disease frontal cortex and increased co-distribution of BACE with the amyloid precursor protein.
Santosa C; Rasche S; Barakat A; Bellingham SA; Ho M; Tan J; Hill AF; Masters CL; McLean C; Evin G
Neurobiol Dis; 2011 Jul; 43(1):176-83. PubMed ID: 21440067
[TBL] [Abstract][Full Text] [Related]
8. Aβ promotes VDAC1 channel dephosphorylation in neuronal lipid rafts. Relevance to the mechanisms of neurotoxicity in Alzheimer's disease.
Fernandez-Echevarria C; Díaz M; Ferrer I; Canerina-Amaro A; Marin R
Neuroscience; 2014 Oct; 278():354-66. PubMed ID: 25168729
[TBL] [Abstract][Full Text] [Related]
9. Lipid alterations in lipid rafts from Alzheimer's disease human brain cortex.
Martín V; Fabelo N; Santpere G; Puig B; Marín R; Ferrer I; Díaz M
J Alzheimers Dis; 2010; 19(2):489-502. PubMed ID: 20110596
[TBL] [Abstract][Full Text] [Related]
10. Low-density lipoprotein receptor-related protein promotes amyloid precursor protein trafficking to lipid rafts in the endocytic pathway.
Yoon IS; Chen E; Busse T; Repetto E; Lakshmana MK; Koo EH; Kang DE
FASEB J; 2007 Sep; 21(11):2742-52. PubMed ID: 17463224
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of disease: new therapeutic strategies for Alzheimer's disease--targeting APP processing in lipid rafts.
Cheng H; Vetrivel KS; Gong P; Meckler X; Parent A; Thinakaran G
Nat Clin Pract Neurol; 2007 Jul; 3(7):374-82. PubMed ID: 17611486
[TBL] [Abstract][Full Text] [Related]
12. Amyloid-β protein (Aβ) Glu11 is the major β-secretase site of β-site amyloid-β precursor protein-cleaving enzyme 1(BACE1), and shifting the cleavage site to Aβ Asp1 contributes to Alzheimer pathogenesis.
Deng Y; Wang Z; Wang R; Zhang X; Zhang S; Wu Y; Staufenbiel M; Cai F; Song W
Eur J Neurosci; 2013 Jun; 37(12):1962-9. PubMed ID: 23773065
[TBL] [Abstract][Full Text] [Related]
13. Dimensional Changes in Lipid Rafts from Human Brain Cortex Associated to Development of Alzheimer's Disease. Predictions from an Agent-Based Mathematical Model.
Santos G; Díaz M
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830060
[TBL] [Abstract][Full Text] [Related]
14. Amyloid beta peptide load is correlated with increased beta-secretase activity in sporadic Alzheimer's disease patients.
Li R; Lindholm K; Yang LB; Yue X; Citron M; Yan R; Beach T; Sue L; Sabbagh M; Cai H; Wong P; Price D; Shen Y
Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3632-7. PubMed ID: 14978286
[TBL] [Abstract][Full Text] [Related]
15. The proteins BACE1 and BACE2 and beta-secretase activity in normal and Alzheimer's disease brain.
Stockley JH; O'Neill C
Biochem Soc Trans; 2007 Jun; 35(Pt 3):574-6. PubMed ID: 17511655
[TBL] [Abstract][Full Text] [Related]
16. Proteolytic processing of the Alzheimer's disease amyloid precursor protein in brain and platelets.
Evin G; Zhu A; Holsinger RM; Masters CL; Li QX
J Neurosci Res; 2003 Nov; 74(3):386-92. PubMed ID: 14598315
[TBL] [Abstract][Full Text] [Related]
17. Characterization of Abeta11-40/42 peptide deposition in Alzheimer's disease and young Down's syndrome brains: implication of N-terminally truncated Abeta species in the pathogenesis of Alzheimer's disease.
Liu K; Solano I; Mann D; Lemere C; Mercken M; Trojanowski JQ; Lee VM
Acta Neuropathol; 2006 Aug; 112(2):163-74. PubMed ID: 16865398
[TBL] [Abstract][Full Text] [Related]
18. Alzheimer disease Abeta production in the absence of S-palmitoylation-dependent targeting of BACE1 to lipid rafts.
Vetrivel KS; Meckler X; Chen Y; Nguyen PD; Seidah NG; Vassar R; Wong PC; Fukata M; Kounnas MZ; Thinakaran G
J Biol Chem; 2009 Feb; 284(6):3793-803. PubMed ID: 19074428
[TBL] [Abstract][Full Text] [Related]
19. Compartmentalization of beta-secretase (Asp2) into low-buoyant density, noncaveolar lipid rafts.
Riddell DR; Christie G; Hussain I; Dingwall C
Curr Biol; 2001 Aug; 11(16):1288-93. PubMed ID: 11525745
[TBL] [Abstract][Full Text] [Related]
20. Exclusively targeting beta-secretase to lipid rafts by GPI-anchor addition up-regulates beta-site processing of the amyloid precursor protein.
Cordy JM; Hussain I; Dingwall C; Hooper NM; Turner AJ
Proc Natl Acad Sci U S A; 2003 Sep; 100(20):11735-40. PubMed ID: 14504402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
